Back to Journals » Clinical Epidemiology » Volume 4 » Issue 1

Prognosis of ruptured abdominal aortic aneurysms in Denmark from 1994–2008

Authors Lindholt J, Søgaard R, Laustsen

Received 21 February 2012

Accepted for publication 16 March 2012

Published 2 May 2012 Volume 2012:4(1) Pages 111—113

DOI https://doi.org/10.2147/CLEP.S31098

Review by Single anonymous peer review

Peer reviewer comments 2



Jes S Lindholt1, Rikke Søgaard2, Jesper Laustsen3
1Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Clinical Institute, University of Aarhus, 2Centre for Applied Health Service Research and Technology Assessment, Institute of Public Health, University of Southern Denmark, 3Department of Vascular Surgery, Aarhus University Hospital, Denmark

Introduction: Few modern population-based estimates of the prognosis of ruptured abdominal aortic aneurysm (rAAA) exist.
Methods and materials: From 1994–2008, a total of 6954 rAAA cases were identified in Danish nationwide population-based registries.
Results: Of 3148 (45%) surgery cases, 1454 (46%) died within 30 days of surgery. The overall mortality risk of rAAA was 76%. The proportion of patients who received surgery increased from 44%, in the first study period, to 47% in the last study period; the 30-day postoperative mortality rate decreased from 51% to 42%; and the overall mortality risk declined significantly from 77% to 74% (odds ratio: 0.86: 95% confidence interval: 0.77–0.97). However, the age-adjusted mortality rate remained unchanged, due to the increased incidence of rAAA.

Keywords: prognosis, ruptured abdominal aortic aneurysm, epidemiology, mortality

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.